Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalmefene effects on postoperative sufentanil PCIA after VATS lung resection
ChiCTR2100049353Phase 4Completed
- Sponsor
- Sichuan Provincial People's Hospital
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nalmefene in postoperative pain (3 arms), sponsored by Sichuan Provincial People's Hospital. Primary endpoint: Dosage of sufentanil in analgesia pump. Started Jul 2021; status: completed.
02
Drugs
nalmefene
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2100049353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049353.